Recs

18

Is Help on the Way for Dow Chemical?

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

There are few beehives busier than Dow Chemical (NYSE: DOW  ) these days. If nothing else, it appears that its rapidly growing agricultural-sciences division may be unloaded or partially sold in the not-too-distant future.

Let's review how we got here: The first thing you need to know is that Michigan-based Dow agreed some time ago to pay $15.3 billion for Philadelphia-based Rohm & Haas (NYSE: ROH  ) , largely a maker of coatings and electrical materials. The tab was based on $78 a share for Rohm & Haas. Those shares closed at $52.07 on Friday. The amount would be partially covered by the $9 billion that Dow would have garnered from a second deal, a $17.4 billion joint venture agreement with Kuwait Petroleum Corp. that would have been called K-Dow Petrochemicals.

That is, until the Kuwaitis became frightened by the world's tumbling economy (and the ups and downs of crude prices) and pulled the plug on their end of the bargain. Which left the folks at Dow scrambling for other ways to complete the Rohm & Haas acquisition. You see, that deal had been signed without a "buyer's remorse" clause, which would have permitted Dow to exit the agreement by paying a penalty. Instead, there's a "ticking fee," which costs Dow $100 million each month the deal isn't consummated.

But help may be on the way. Dow appears to be in talks with a group of private-equity firms, including The Blackstone Group (NYSE: BX  ) . The potential deal apparently would involve a minority stake in the agricultural-sciences division to help fund the Rohm & Haas purchase.

And then there's the possibility of interest from Syngenta AG (NYSE: SYT  ) , a Swiss crop sciences company, which would be more likely to purchase the unit in its entirety. Beyond that, DuPont (NYSE: DD  ) and Monsanto (NYSE: MON  ) have similar businesses that could justify their joining the chase.

All this tends to increase my interest in Dow, a company whose management has been attempting to guide toward increased profitability. Unfortunately, they've been ambushed along the way. Now that competing cavalries having been spotted mounting the nearest hill, we may be in for a tussle well worth Foolish attention.

For related Foolishness:

The Steve Jobs Betrayal
You may already know that in the final year of his life, Jobs revealed a stunning betrayal — and told his biographer, "I will spend my last dying breath... and every penny of Apple's $40 billion in the bank to right this wrong." What was it that made Jobs so irate — and why could it make a few in-the-know investors some major profits over the coming months and years?

Enter your email address below to find out what made Jobs so enraged!

Fool contributor David Lee Smith doesn't own shares in any of the companies named above. He does, however, welcome your questions or comments. The Fool has a disclosure policy.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On March 02, 2009, at 9:26 PM, redclaymud wrote:

    Thanks for your foolish interest in Dow Chemical. Many of us fools have been beaten down by this stock. Send in the troops!

  • Report this Comment On March 03, 2009, at 12:13 PM, JesseLiverSore wrote:

    They were "ambushed?"

    I am amazed that you are such an apologist for Liveris and the management. By my tally, they have:

    1) failed to close 2 key deals

    2) failed to legally protect their shareholders in contract negotiations

    3) failed to protect against a downturn in the economy

    Do you remember how cocky CEO Liveris was when he came on CNBC to announce the Rohm deal? He was sooooo sure the outrageous premium was worth it.

    He has failed the company and the shareholders.

Add your comment.

Compare Brokers

Fool Disclosure

DocumentId: 842373, ~/Articles/ArticleHandler.aspx, 5/25/2012 8:56:34 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 12,454.83 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
NASD 2,837.53 -1.85 -0.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/25/2012 4:00 PM
DOW $31.30 Down -0.25 -0.79%
The Dow Chemical C… CAPS Rating: ****
ROH $78.94 Down +0.00 +0.00%
Rohm and Haas Comp… CAPS Rating: **
SYT $63.85 Down -0.14 -0.22%
Syngenta CAPS Rating: *****
MON $73.56 Down -0.38 -0.51%
Monsanto Company CAPS Rating: ****
BX $12.26 Up +0.25 +2.08%
The Blackstone Gro… CAPS Rating: ****
DD $48.40 Down -0.26 -0.53%
E.I. du Pont de Ne… CAPS Rating: ****

Advertisement